GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » PEG Ratio

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) PEG Ratio : 1.23 (As of Apr. 27, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Zhejiang Cheng Yi Pharmaceutical Co's PE Ratio without NRI is 16.56. Zhejiang Cheng Yi Pharmaceutical Co's 5-Year EBITDA growth rate is 13.50%. Therefore, Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio for today is 1.23.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio or its related term are showing as below:

SHSE:603811' s PEG Ratio Range Over the Past 10 Years
Min: 0.57   Med: 3.35   Max: 56.72
Current: 1.23


During the past 13 years, Zhejiang Cheng Yi Pharmaceutical Co's highest PEG Ratio was 56.72. The lowest was 0.57. And the median was 3.35.


SHSE:603811's PEG Ratio is ranked better than
62.33% of 361 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs SHSE:603811: 1.23

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Zhejiang Cheng Yi Pharmaceutical Co PEG Ratio Historical Data

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Cheng Yi Pharmaceutical Co PEG Ratio Chart

Zhejiang Cheng Yi Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.34 2.51 8.05

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.12 8.05 9.32 50.72 40.61

Competitive Comparison of Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio falls into.


;
;

Zhejiang Cheng Yi Pharmaceutical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=16.557692307692/13.50
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Zhejiang Cheng Yi Pharmaceutical Co  (SHSE:603811) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Zhejiang Cheng Yi Pharmaceutical Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Cheng Yi Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 988, Shenhong Road, 7th Floor, No. 9, Building 20, Fuli Yuedu, Minhang District, Shanghai, CHN, 201100
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
Executives
Ke Ze Hui Director
Ren Bing Jun Director
Yan Yi Yi Director
Ceng Huan Qun Director
Li Shi Sheng Director
Qiu Ke Rong Director
Lv Sun Zhan senior management
Zhang Gao Qiao Supervisors
Zhang Zhi Hong senior management
Mao Li Ping senior management
Zhuang Xiao Ping Director
Lin Xin Chen senior management
Shen Ai Lan Director
Zhang Fu Fu Supervisors

Zhejiang Cheng Yi Pharmaceutical Co Headlines

No Headlines